Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
-
Randomized Controlled Trial Multicenter Study
Safety and Effectiveness of VYC-15L, a Hyaluronic Acid Filler for Lip and Perioral Enhancement: One-Year Results From a Randomized, Controlled Study.
VYC-15L (Juvéderm Volbella XC) is a nonanimal crosslinked hyaluronic acid (HA) gel with lidocaine. ⋯ VYC-15L was safe and effective for lip and perioral enhancement, with treatment effects lasting through 1 year.
-
Randomized Controlled Trial Multicenter Study
Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: Results After Repeat Treatment.
Juvéderm Voluma XC (VYC-20L; hyaluronic acid gel) is approved in the United States for correction of age-related midface volume deficit (MVD). ⋯ Repeat treatment with VYC-20L was well tolerated and resulted in high levels of effectiveness and subject satisfaction.
-
Randomized Controlled Trial Multicenter Study
Safety and Effectiveness of the Hyaluronic Acid Filler, HYC-24L, for Lip and Perioral Augmentation.
Hyaluronic acid gels are increasingly used for augmentation of the lips. ⋯ HYC-24L is safe and effective for aesthetic lip augmentation, with results lasting up to 1 year.
-
Randomized Controlled Trial Multicenter Study
HYC-24L Demonstrates Greater Effectiveness With Less Pain Than CPM-22.5 for Treatment of Perioral Lines in a Randomized Controlled Trial.
This trial compares the effectiveness and safety of HYC-24L (Juvéderm Ultra XC; Allergan plc, Dublin, Ireland) (24 mg/mL of hyaluronic acid, 0.3% lidocaine) and CPM-22.5 (Belotero Balance; Merz Aesthetics, Raleigh, NC) (22.5 mg/mL of hyaluronic acid) for the treatment of perioral lines. ⋯ HYC-24L subjects showed a higher response rate and a greater improvement in their perioral lines than CPM-22.5 subjects for up to 6 months.
-
Randomized Controlled Trial Multicenter Study
Duration of effect by injection volume and facial subregion for a volumizing hyaluronic acid filler in treating midface volume deficit.
Juvéderm Voluma XC (VYC-20L) is approved in the United States for correction of age-related volume loss in the midface region in adults. ⋯ VYC-20L is effective at restoring midface volume, with high subject satisfaction and an acceptable safety profile.